Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Ellipta device
Time to teach and ease of use for the Ellipta device
COPD education: learn more about Chronic Obstructive Pulmonary Disease (COPD)
Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol) is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) or a combination of a LABA and a long-acting muscarinic antagonist (LAMA).1
Enhance your COPD knowledge with this series of educational modules designed for healthcare professionals. Whether you are looking to strengthen your understanding of COPD, improve the quality of patient reviews, optimise disease management or refresh your knowledge of inhaler therapies, these practical learning resources provide accessible, clinically relevant education to support everyday practice and patient outcomes.
Module 1: COPD 101
Use this module to explore and understand the complexity and burden of COPD that sits behind the urgency to treat it. This module is suitable for healthcare professionals who want to strengthen their understanding of COPD, its impact on patients and the importance of timely intervention
Module 3: COPD Management
Use this module to gain an in-depth understanding of guideline-recommended tools, the mode of action of molecules in inhaled therapy and how to confidently optimise treatment for your patients with COPD. This module is suitable for healthcare professionals who want to strengthen their knowledge of inhaled therapies, treatment guidelines and evidence-based approaches to COPD management
Module 4: COPD Inhalers
Use this module to understand the importance of selecting the most appropriate inhaler device for you patients. Gain an understand of how teaching correct use can support your patients to get the most from their medication. This module is suitable for healthcare professionals who want to gain confidence in inhaler device selection.
Module 5: Discussing the environmental impact of COPD inhalers with patients
Use this module to increase your understanding of the environmental impact of inhalers and how to engage your patient in these discussions. This module is suitable for healthcare professionals who want to support their patient to reduce carbon emissions associated with inhaler use.
Looking to build your patient consultation skills?
Visit our Inhale hub for consultation support
Information to support COPD consultations with your patients
Access clinical evidence and practical guidance for appropriate patients
Resources to support ongoing COPD management
Request a contact
If you would like one of our representative, account managers, medical or scientific colleagues to contact you, please click on the link and fill out the form
Are you looking for something else?
Stay informed by email
Sign up to receive emails from GSK (may contain promotional information)
Resources
Support your patients with these healthcare resources
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441, via email: uksafety@gsk.com or at https://gsk.public.reportum.com/
October 2026 | PM-GB-FVU-WCNT-260009 (V1.0)
